EUVIMEDEUVIMED entdecken
Crossref

Establishment of Non‐Target Screening and Quantitative Analysis Strategy Based on UHPLC Coupled With Orbitrap Exploris 240 and QqQ Mass Spectrometry to Improve the Quality Control of Ziyu Ointment

Man Liao, Jingnan Hu, Zhongwen Xi, Shengjiang Guan, Jihua Gao, Jie Cheng, Tao He

Journal of Separation Science · 2026

DOI: 10.1002/jssc.70437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Separation Science, 2026. Verfasst von Man Liao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Hebei Provincial Hospital of Chinese Medicine, Shijiazhuang, Hebei, People's Republic of China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: the Scientific Research Programme of Hebei Provincial Administration of Traditional Chinese Medicine, National Natural Science Foundation of China, the Government Funded Clinical Program of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ziyu ointment (ZYO) is a commonly used, approved ingredient in traditional Chinese medicine (TCM) medication for treating superficial swelling and ulcers. However, due to limited methodologies, more accurate and selective qualitative and quantitative analysis methods for its active ingredients have not yet been established. This impedes both the full clinical development and application of ZYO as well as the clarification of its pharmacological mechanism. In this research, a rapid and sensitive UHPLC‐Orbitrap Exploris MS method with higher‐energy collisional dissociation (HCD) was established for identifying ZYO's chemical components. A total of 167 chemical components were found, including 34 carboxylic acids and esters, 32 phenylpropanoids, 27 terpenoids, 18 flavonoids, 12 naphthoquinones, 11 phthalides, 8 phenolic acids, 5 phenols, 3 steroids, 2 quinones, 2 alkaloids, and 13 miscellaneous compounds. Among these, UHPLC‐QqQ‐MS/MS was used to simultaneously determine 12 analytes (either with high contents or significant bioactivities), namely, (1) loganin, (2) sweroside, (3) ferulic acid, (4) senkyunolide I, (5) bergapten, (6) ziyuglycoside II, (7) imperatorin, (8) shikonin, (9) ligustilide, (10) isoimperatorin, (11) β‐hydroxyisovalerylshikonin, and (12) levistilide A. The foundation for future use and quality assurance of the active ingredients in ZYO was established by this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalChromatography, High Pressure LiquidQuality ControlOintmentsTandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryMass Spectrometry

Stichwörter der Autor:innen

QqQ mass spectrometryZiyu ointmenthigher‐energy collisional dissociation (HCD)orbitrap mass spectrometry

Substanzen

OintmentsDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Pharmacy, Hebei Provincial Hospital of Chinese Medicine, Shijiazhuang, Hebei, People's Republic of China.
  • School of Integrated Traditional Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, People's Republic of China.
  • Key Laboratory of Evaluation and Transformation of Chinese Medicine Under Hebei Provincial Administration of Chinese Medicine, Shijiazhuang, Hebei, People's Republic of China.
  • Hebei Industrial Technology Institute for Traditional Chinese Medicine Preparation, Shijiazhuang, Hebei, People's Republic of China.
  • Department of Anorectal Medicine, Hebei Provincial Hospital of Chinese Medicine, Shijiazhuang, Hebei, People's Republic of China.
  • Department of Anesthesiology, Hebei Provincial Hospital of Chinese Medicine, Shijiazhuang, Hebei, People's Republic of China.

Förderung

  • the Scientific Research Programme of Hebei Provincial Administration of Traditional Chinese Medicine
  • National Natural Science Foundation of China
  • the Government Funded Clinical Program of Hebei Province

Zitieren

APA

Liao, M., Hu, J., Xi, Z., Guan, S., Gao, J., Cheng, J., & He, T. (2026). Establishment of Non‐Target Screening and Quantitative Analysis Strategy Based on UHPLC Coupled With Orbitrap Exploris 240 and QqQ Mass Spectrometry to Improve the Quality Control of Ziyu Ointment. Journal of Separation Science. https://doi.org/10.1002/jssc.70437

Vancouver

Liao M, Hu J, Xi Z, Guan S, Gao J, Cheng J, et al. Establishment of Non‐Target Screening and Quantitative Analysis Strategy Based on UHPLC Coupled With Orbitrap Exploris 240 and QqQ Mass Spectrometry to Improve the Quality Control of Ziyu Ointment. Journal of Separation Science. 2026. doi:10.1002/jssc.70437

BibTeX
@article{Liao2026,
  author = {Liao, Man and Hu, Jingnan and Xi, Zhongwen and Guan, Shengjiang and Gao, Jihua and Cheng, Jie and He, Tao},
  title = {Establishment of Non‐Target Screening and Quantitative Analysis Strategy Based on UHPLC Coupled With Orbitrap Exploris 240 and QqQ Mass Spectrometry to Improve the Quality Control of Ziyu Ointment},
  journal = {Journal of Separation Science},
  year = {2026},
  doi = {10.1002/jssc.70437}
}
Kostenlos starten →